// App-Quantinova.ai

5092 : CD151-31 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion

Researchers

Presenter

  • Pengcheng Zhou

Principal Investigators

  • Sonia Erfani

  • Rosalind Segal

  • Craig Horbinski

  • Xiuwei H. Yang

Medical Centers

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

  • Dept of Pharmacology & Nutritional Sciences, University of Kentucky, Lexington, KY

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • Dept. of Pathology, University of Kentucky, Lexington, KY.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Brain cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor

  • Epidermal growth factor receptor

  • Focal Adhesion Kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved